The Latest Advances of Alzheimer's

1
The Latest Advances of Alzheimer'sby
HOME CARE ASSISTANCE FORTMYERS
2

• While there is still no cure for Alzheimer's, new
  advances are made every year in the fight against
  the disease. Researchers are studying new
  treatments to improve the quality of life and
  slow the progression of the disease as well as
  ways to identify the disease before symptoms
  appear. Every new development builds momentum in
  the race for a cure. Here are some of the latest
  developments in the fight against Alzheimer's.

3
Immunization Therapy May Fight Beta-Amyloid Plaque

• One of the newest dementia treatments in
  development aims to immunize the body against
  producing clumps of beta-amyloid in the brain, a
  hallmark sign of Alzheimer's. A recent
  Alzheimer's vaccine clinical trial worked to
  mobilize a person's immune system to fight
  beta-amyloid in the brain.
• While this study was ended early after some
  participants developed brain inflammation, the
  study found that immunization may be a solution.
  Immunization studies going forward will focus on
  administered antibodies against beta-amyloid
  plaque from an outside source rather than
  boosting a person's immune system.

4
Hormone Therapy May Prevent Dementia in Women

• Hormone replacement therapy is already known to
  prevent the development of osteoporosis in women.
  A new study suggests it may lower the risk of
  Alzheimer's as well for women who are at high
  risk for the disease. Women who carry a common
  genetic risk factor for Alzheimer's experience
  more rapid aging of their cells. In the study,
  women at high risk of Alzheimer's who received
  hormone therapy showed no evidence of telomere
  shortening, or cell aging, after one year.
  Reducing the risk of cellular aging is believed
  to lower the changes of Dementia.

5
Blood Test for Early Detection

• One of the greatest breakthroughs in Alzheimer's
  testing came in 2015 when researchers identified
  a single blood protein that may serve as a
  warning for mild cognitive impairment, a disorder
  that's usually a precursor to dementia.
  Researchers found that, after following healthy
  adults for more than a decade, those whose
  cognitive skills diminished the most had the
  lowest levels of a particular protein.
• Researchers hope this blood protein may be used
  to develop a simple blood test that can determine
  who's at risk of developing Alzheimer's within
  the next ten years. Early diagnosis can give
  families and patients more time to prepare and
  slow the progression of the disease.

6
Drug to Reduce Cognitive Decline

• Another breakthrough in Alzheimer's research this
  year is a drug called solanezumab. Manufactured
  by Eli Lilly, the drug has been found to reduce
  the rate at which the disease breaks down the
  brain by up to 34. Data from the clinical trials
  found that solanezumab reduced cognitive decline
  in patients with mild Alzheimer's. This is the
  first time this has ever been recorded.
• Solanezumab works by targeting amyloid proteins
  in the brain and getting rid of them. While the
  first clinical trial in 2012 involving people
  with mild to moderate Alzheimer's was deemed a
  failure initially, researchers reviewed data and
  found that that advancement of the disease in
  persons with mild forms appeared to have slowed
  dramatically. It's believed that the drug may be
  very beneficial if prescribed to Alzheimer's
  patients in the early stages of the disease. A
  third clinical trial has already started to test
  the drug on people with mild Alzheimer's. The
  results are expected in 2017.

7
About us

• If you or an elderly loved one needs high quality
  home care or meaningful companionship, we at Home
  Care Assistance of Fort Myers are here to help.
• Call [phone] to speak with a Care Manager
  now.

8
Thanks for watching

• Address 3605 Tamiami Trail N.Naples, FL 34103
• Web http//homecareassistancefortmyers.co
  m/